Biotech and Pharma Stocks

Small Caps is Australia's #1 site for market news & information on ASX listed small cap companies.

Small Caps and affiliated companies accept no responsibility for any claim, loss or damage as a result of information provided or its accuracy. The information provided on this site is general in nature, not financial product advice, see a financial expert before making any investment decision. Your personal objectives, financial situation or needs have not been taken into consideration. There may be a conflict of interest present with commercial arrangements with companies and/or stock held. Small Caps or an associate may receive a commission for funds raised.

BIOTECH & PHARMA

Amplia Therapeutics completes design of phase 2 AMP945 trial to treat advanced pancreatic cancer

Argenica Therapeutics produces GMP-grade ARG-007 for prevention of brain tissue death in stroke patients

Epsilon Healthcare partners with Valens to produce medicinal cannabis for global markets

Invion advances ‘exciting’ photodynamic therapy to treat a range of cancers

Little Green Pharma takes delivery of first cannabis flower shipment from new Danish growing facility

Little Green Pharma grows full-year profits to record $24.6m

Osteopore’s regenerative bone implants to be further developed under new clinical trials

Invion Group to expand its promising photodynamic therapy technology into new markets

Prescient Therapeutics appoints leading brain cancer specialist to advisory board

Incannex Healthcare proposes US IPO and Nasdaq listing

Invex Therapeutics collars European patent for elevated intracranial pressure treatment

Cannvalate divests MDMA business in $2.72m deal to address chronic pain management

Incannex Healthcare submits proposals for phase two psychedelics study to treat generalised anxiety disorder

After ‘tremendous’ FY 2021, Prescient Therapeutics well-funded to advance cancer-fighting therapies

Emyria and University of Western Australia to research MDMA compounds for treatment of mental health disorders

Osteopore improves margins ahead of forecast increase in elective surgeries

Amplia Therapeutics prepares for phase two AMP945 trial backed by shareholders

Little Green Pharma posts ‘transformational quarter’ of acquisition and distribution deals

Incannex Healthcare begins clinical trial using IHL-675A soft gel capsules

Invex Therapeutics closes busy quarter of development on Presendin for idiopathic intracranial hypertension

PharmAust lodges patent application for the use of monepantel in viral diseases